Clinical Trial: Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms

U.S., May 3 -- ClinicalTrials.gov registry received information related to the study (NCT06955533) titled 'Single Dose Versus Double Dose Tamsulosin 0.4 and Solifenacin 5 in Management of Stent Related Symptoms' on April 25.

Brief Summary: This study was a randomized clinical trial conducted on 64 Egyptian patients from the outpatient clinic at Ain Shams University Hospital over a six-month period from 3/2024 to 9/2024.The study population was randomized into 2 groups. Group A included 32 patients with stent related symptoms receiving double doses of tamsulosin (Tamsulin(R) 0.4 mg 2 capsules taken together per day) and Solifenacin 10mg (Sofenacin(R) 10mg tab taken once daily).Group B included 32 patients with stent related symptoms receivi...